Drug intelligence / Profile preview

technetium (99mTc) tetrofosmin

Development stage
Unknown
Lead developer
GE Healthcare
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Technetium (99mTc) tetrofosmin is an approved diagnostic radiopharmaceutical used as a SPECT imaging agent for myocardial perfusion imaging (MPI). It consists of the radioisotope technetium-99m chelated by two tetrofosmin ligands (1,2-bis[di-(2-ethoxyethyl)phosphino]ethane). Following intravenous administration, the lipophilic cationic complex is rapidly taken up by myocardial tissue in proportion to regional blood flow and sequestered within mitochondria. It is primarily indicated for the delineation of reversible myocardial ischemia and infarcted myocardium in patients with known or suspected coronary artery disease, as well as for the assessment of left ventricular function.

Brand names
Myoview
Other names
technetium Tc 99m tetrofosmin99mTc-tetrofosmintechnetium Tc 99m tetrofosmin injectionTechnetium[99mTc] Tetrofosmin Injection

Beyond the preview

Go deeper on technetium (99mTc) tetrofosmin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium (99mTc) tetrofosmin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call